Despite how hard we may try to scrub ourselves clean with antibacterial soap, it appears that humans are more tightly bound to our surrounding microbes than we thought. [ + ]

Alchemia's (ASX:ACL) share of the profits from sales of anti-coagulant generic fondaparinux declined in FY14, but the company expects business to pick up from 2015. [ + ]

​The newly formed Medical Research Future Fund (MRFF) Action Group is advocating for what it claims to be the most important initiative in Australian medical research in generations. [ + ]

RMIT University has opened its new MicroNano Research Facility (MNRF) - a $30 million, 1200 m² building that will drive cutting-edge advances in micro- and nanotechnologies, supporting projects that span across the traditional disciplines of physics, chemistry, engineering, biology and medicine. [ + ]

The AFL has added Regeneus (ASX:RGS) HiQCell to a list of approved treatments for injuries including impact-related osteoarthritis and tendonitis. [ + ]

Vaxxas has been selected as a 2015 Technology Pioneer by the World Economic Forum for its patch-based vaccine delivery technology. [ + ]

​Two separate studies into the oilseed crop canola are providing vital information that will help improve crop yields. An international genome study has shed light on the historical origins of canola, while researchers have also discovered the key to understanding what makes Australian canola flower earlier than its Canadian and European counterparts. [ + ]

Former Alchemia (ASX:ACL) chief Charles Walker has taken the role of Imugene (ASX:IMU) CEO, to help lead the company's efforts to commercialise HER-Vaxx in gastric cancer. [ + ]

One of the biggest problems for conservation today is that it ignores 95% of all known species on Earth. Could a company ignore that proportion of its clients or a government so many of its voters? So why does this problem exist in conservation? [ + ]

Regeneus (ASX:RGS) and Cryosite (ASX:CTE) have agreed to share technology and expertise in the area of stem cell products for human applications. [ + ]

Sirtex Medical (ASX:SRX) has posted a 30.6% increase in profit for FY14, as dose sales of its SIR-Spheres liver cancer treatment reached a record high. [ + ]

The upcoming Annual Scientific Conference of the Australasian Association of Clinical Biochemists (AACB) will focus on Clinical Biochemistry Supporting P4 Medicine - the four 'Ps' representing personalised, predictive, preventive and participatory. [ + ]

Researchers from the University of Utah have discovered a method for turning a small, $40 needle into a 3D microscope capable of taking images up to 70 times smaller than the width of a human hair. [ + ]

The value of an artwork can vary by orders of magnitude if its provenance can be established; increasingly, science is coming to the aid of curators to prove provenance. [ + ]

Innate Immunotherapeutics (ASX:IIL) announced that WANRI - lead site for its phase IIb trial of MIS416 in secondary progressive multiple sclerosis - has been cleared to start recruiting patients. [ + ]